As CVS Health continues to deal with the closure of its $69 billion acquisition of Aetna, its pharmacy benefit manager (PBM) branch is moving ahead with a new pricing model. The new focus could help guarantee net cost predictability and simplify pricing.

CVS Health has closed its $69 billion acquisition of health insurer Aetna after the deal was approved by all necessary regulators, but the transaction has hit a snag after a judge requested more information from the Department of Justice.

In the midst of a major consolidation period in the healthcare industry, a new report from the Trump administration sheds light on the current state of competition in the space.

While the $69 billion merger between CVS Health and Aetna has been approved by regulators and cleared by the Department of Justice, a federal judge has raised the prospect of not approving the deal, CNBC reported.

States will have more flexibility to introduce new healthcare options to residents under a new policy from CMS that impacts waivers.

The healthcare industry is in a period of rapid consolidation, with major mergers and acquisitions happening year to year. This consolidation is leading to high concentration levels in 73 percent of health insurance markets, according to a recent study from the American Medical Association.

The ongoing merger between CVS Health and Aetna officially closed Nov. 28, the companies announced. The $69 billion deal brings together one of the nation’s largest health insurers and retail pharmacy chains and pharmacy benefit managers.

The completion of the $67 billion merger between health insurer Cigna and Express Scripts has been delayed, according to a public filing. The deal was anticipated to close by December 8, but the companies have decided to delay that deadline by six months.